Annual Current Assets
$240.18 M
-$111.22 M-31.65%
31 December 2023
Summary:
Foghorn Therapeutics annual total current assets is currently $240.18 million, with the most recent change of -$111.22 million (-31.65%) on 31 December 2023. During the last 3 years, it has risen by +$49.49 million (+25.96%). FHTX annual current assets is now -47.74% below its all-time high of $459.56 million, reached on 31 December 2021.FHTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$271.23 M
-$18.39 M-6.35%
30 September 2024
Summary:
Foghorn Therapeutics quarterly total current assets is currently $271.23 million, with the most recent change of -$18.39 million (-6.35%) on 30 September 2024. Over the past year, it has increased by +$5.79 million (+2.18%). FHTX quarterly current assets is now -40.98% below its all-time high of $459.56 million, reached on 31 December 2021.FHTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.6% | +2.2% |
3 y3 years | +26.0% | +118.8% |
5 y5 years | +494.5% | - |
FHTX Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -47.7% | +26.0% | -41.0% | +118.8% |
5 y | 5 years | -47.7% | +1322.5% | -41.0% | +1506.4% |
alltime | all time | -47.7% | +1322.5% | -41.0% | +1506.4% |
Foghorn Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $271.23 M(-6.3%) |
June 2024 | - | $289.62 M(+36.9%) |
Mar 2024 | - | $211.52 M(-11.9%) |
Dec 2023 | $45.73 M(-14.5%) | $240.18 M(-9.5%) |
Sept 2023 | - | $265.44 M(-8.6%) |
June 2023 | - | $290.49 M(-9.4%) |
Mar 2023 | - | $320.70 M(-8.7%) |
Dec 2022 | $53.48 M | $351.40 M(-7.0%) |
Sept 2022 | - | $377.76 M(-5.6%) |
June 2022 | - | $400.07 M(-6.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $429.82 M(-6.5%) |
Dec 2021 | $60.21 M(-7.2%) | $459.56 M(+270.8%) |
Sept 2021 | - | $123.95 M(-14.3%) |
June 2021 | - | $144.67 M(-12.5%) |
Mar 2021 | - | $165.31 M(-13.3%) |
Dec 2020 | $64.91 M(+1089.4%) | $190.69 M(+145.2%) |
Sept 2020 | - | $77.76 M(+99.6%) |
June 2020 | - | $38.97 M(+130.8%) |
Dec 2019 | $5.46 M(+105.5%) | $16.89 M |
Dec 2018 | $2.66 M | - |
FAQ
- What is Foghorn Therapeutics annual total current assets?
- What is the all time high annual current assets for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual current assets year-on-year change?
- What is Foghorn Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly current assets year-on-year change?
What is Foghorn Therapeutics annual total current assets?
The current annual current assets of FHTX is $240.18 M
What is the all time high annual current assets for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual total current assets is $459.56 M
What is Foghorn Therapeutics annual current assets year-on-year change?
Over the past year, FHTX annual total current assets has changed by -$111.22 M (-31.65%)
What is Foghorn Therapeutics quarterly total current assets?
The current quarterly current assets of FHTX is $271.23 M
What is the all time high quarterly current assets for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly total current assets is $459.56 M
What is Foghorn Therapeutics quarterly current assets year-on-year change?
Over the past year, FHTX quarterly total current assets has changed by +$5.79 M (+2.18%)